Moody's Investors Service affirms Catalent Pharma Solutions at "B1" (LT- local currency credit rating); outlook stable
March 2, 2020 CBonds
Show full article |
This functionality is available for registred users only
|
Company — Catalent Pharma Solutions

-
Full nameCatalent Pharma Solutions, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
Share